Demonstrating Immersive Media Delivery on 5G Broadcast and Multicast Testing Networks

This work presents eight demonstrators and one showcase developed within the 5G-Xcast project. They experimentally demonstrate and validate key technical enablers for the future of media delivery, associated with multicast and broadcast communication capabilities in 5th Generation (5G). In 5G-Xcast, three existing testbeds: IRT in Munich (Germany), 5GIC in Surrey (UK), and TUAS in Turku (Finland), have been developed into 5G broadcast and multicast testing networks, which enables us to demonstrate our vision of a converged 5G infrastructure with fixed and mobile accesses and terrestrial broadcast, delivering immersive audio-visual media content. Built upon the improved testing networks, the demonstrators and showcase developed in 5G-Xcast show the impact of the technology developed in the project. Our demonstrations predominantly cover use cases belonging to two verticals: Media & Entertainment and Public Warning, which are future 5G scenarios relevant to multicast and broadcast delivery. In this paper, we present the development of these demonstrators, the showcase, and the testbeds. We also provide key findings from the experiments and demonstrations, which not only validate the technical solutions developed in the project, but also illustrate the potential technical impact of these solutions for broadcasters, content providers, operators, and other industries interested in the future immersive media delivery.Comment: 16 pages, 22 figures, IEEE Trans. Broadcastin

Demonstrating Immersive Media Delivery on 5G Broadcast and Multicast Testing Networks

This work presents eight demonstrators and one showcase developed within the 5G-Xcast project. They experimentally demonstrate and validate key technical enablers for the future of media delivery, associated with multicast and broadcast communication capabilities in 5th Generation (5G). In 5G-Xcast, three existing testbeds: IRT in Munich (Germany), 5GIC in Surrey (UK), and TUAS in Turku (Finland), have been developed into 5G broadcast and multicast testing networks, which enables us to demonstrate our vision of a converged 5G infrastructure with fixed and mobile accesses and terrestrial broadcast, delivering immersive audio-visual media content. Built upon the improved testing networks, the demonstrators and showcase developed in 5G-Xcast show the impact of the technology developed in the project. Our demonstrations predominantly cover use cases belonging to two verticals: Media & Entertainment and Public Warning, which are future 5G scenarios relevant to multicast and broadcast delivery. In this paper, we present the development of these demonstrators, the showcase, and the testbeds. We also provide key findings from the experiments and demonstrations, which not only validate the technical solutions developed in the project, but also illustrate the potential technical impact of these solutions for broadcasters, content providers, operators, and other industries interested in the future immersive media delivery

The clinical features and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii infections at a tertiary hospital in Vietnam

ABSTRACT: Objectives: To characterise the clinical features of Acinetobacter baumannii infections and investigate the phylogenetic structure and transmission dynamics of A. baumannii in Vietnam. Methods: Between 2019 and 2020, a surveillance of A. baumannii (AB) infections was conducted at a tertiary hospital in Ho Chi Minh City, Vietnam. Risk factors for in-hospital mortality were analysed using logistic regressions. Whole-genome sequence data were used to characterise genomic species, sequence types (STs), antimicrobial resistance genes, surface antigens, and phylogenetic relatedness of AB isolates. Results: Eighty-four patients with AB infections were enrolled in the study, 96% of whom were hospital-acquired. Half of the AB isolates were identified from ICU-admitted patients, while the remaining isolates were from non-ICU patients. The overall in-hospital mortality was 56%, with associated risk factors including advanced age, ICU stay, exposure to mechanical ventilation/central venous catheterization, pneumonia as source of AB infection, prior use of linezolid/aminoglycosides, and AB treatment with colistin-based therapy. Nearly 91% of isolates were carbapenem-resistant; 92% were multidrug-resistant; and 6% were colistin-resistant. ST2, ST571, and ST16 were the three dominant carbapenem-resistant A. baumannii (CRAB) genotypes, exhibiting distinct AMR gene profiles. Phylogenetic analysis of CRAB ST2 isolates together with previously published ST2 collection provided evidence of intra- and inter-hospital transmission of this clone. Conclusions: Our study highlights a high prevalence of carbapenem resistance and multidrug resistance in A. baumannii and elucidates the spread of CRAB within and between hospitals. Strengthening infection control measures and routine genomic surveillance are crucial to reducing the spread of CRAB and detecting novel pan-drug-resistant variants in a timely fashion